A 45-year-old woman from Puerto Rico presented to the emergency department with progressively worsening dyspnea over a 3-to 4-day period. She had been diagnosed with type 1 Hermansky-Pudlak syndrome complicated by pulmonary fi brosis 4 years earlier. Previous renal biopsy demonstrated nephrosclerosis secondary to HermanskyPudlak syndrome. A brother also had Hermansky-Pudlak syndrome complicated by pulmonary fi brosis. Despite receiving 6 L of oxygen via nasal cannula at home, her oxygen saturation had fallen to 80% to 85%. She was subsequently admitted to the intensive care unit and intubated. Broad-spectrum antibiotics were initiated for a presumptive diagnosis of pneumonia.
A chest radiograph obtained at the time of admission showed reticular opacities throughout the bilateral lungs (Figure 1 ). Th ere was no evidence of consolidation. Contrast-enhanced chest computed tomography (CT) demonstrated extensive subpleural honeycombing, consistent with pulmonary fi brosis (Figures 2 and 3) . Patchy ground-glass opacity was also present bilaterally. Th e patient had been scheduled for lung and kidney transplant but had fatal cardiac arrest in the intensive care unit and died.
DISCUSSION
Hermansky-Pudlak syndrome is a genetic disorder characterized by oculocutaneous albinism, platelet dysfunction, and accumulation of ceroid-lipofuscin, a lipid-protein complex, in lysosomes (1) . Th e diagnosis is typically made by the presence of skin and hair hypopigmentation, characteristic ocular abnormalities, and the absence of dense bodies in platelets on microscopic evaluation. It is inherited in an autosomal recessive manner. Nine types of Hermansky-Pudlak syndrome have been described, most of which are associated with a mutation in the HPS gene on the long arm of chromosome 10. Most of the patients in whom the disorder has been identifi ed and characterized are of Puerto Rican descent (2, 3) .
Th e disease primarily aff ects the lungs, heart, gastrointestinal tract, and kidneys. Symptoms are predominantly related to pulmonary fi brosis, its major complication, and result from deposition of ceroid-lipofuscin within the lungs. Th e interalveolar septa are typically thickened by fi brous tissue (4). Patients with type 1 Hermansky-Pudlak syndrome due to a mutation in the HPS1 gene are more likely to develop pulmonary fi brosis and typically have lung disease of a greater severity than patients without this mutation. Th e prognosis is poor, and patients usually die from pulmonary fi brosis in the fourth to fi fth decades of life.
Important preventive health measures include infl uenza and pneumococcal vaccinations and avoidance of cigarette smoke. Patients are typically treated with oxygen in an attempt to alleviate dyspnea. High-dose corticosteroids have not been shown to be eff ective. An antibiotic, pirfenidone, may slow the progression of pulmonary fi brosis but is eff ective only in patients with signifi cant residual lung function. Th e only defi nitive treatment for pulmonary fi brosis related to Hermansky-Pudlak syndrome is lung transplantation, few cases of which have been successfully performed (5, 6) . Chest radiographs may be normal in patients with Hermansky-Pudlak syndrome at the time of presentation. Th e most common abnormalities detected on radiography include reticular opacities, perihilar fi brosis, pleural thickening, and peribronchovascular opacities (6, 7) . Th e predominant fi ndings on high-resolution chest CT diff er somewhat as the disease progresses. For instance, the most common abnormalities in cases of minimal severity include interlobular septal thickening, reticular opacities, ground-glass opacity, and subpleural honeycombing. In cases of moderate severity, reticular opacities and subpleural honeycombing are present to a greater extent than in cases of minimal severity. Additionally, a wider range of fi ndings is typically present, including bronchiectasis, peribronchovascular thickening, and pleural thickening. Interlobular septal thickening is not a prominent feature, as in cases of minimal severity. In severe cases, subpleural honeycombing and bronchiectasis are more common than in cases of moderate severity. Subpleural reticular opacities, ground-glass opacity, and peribronchovascular thickening are also present. In general, these imaging fi ndings predominantly occur within the periphery of the lung. As the disease progresses, the central portions of the lung become involved. Additionally, an atypical pattern has been described in which the peripheral lung is spared. Patients with greater severity of lung disease at the time of imaging typically have lower forced vital capacity on pulmonary function tests and decreased survival time compared with patients whose lung disease is less severe (6). 
